Alternations in miR-155 and miR-200 serum levels can serve as biomarkers for COVID-19 in the post-mass vaccination era
- PMID: 38796651
- DOI: 10.1007/s11033-024-09630-2
Alternations in miR-155 and miR-200 serum levels can serve as biomarkers for COVID-19 in the post-mass vaccination era
Abstract
Background: Mass vaccination and natural immunity reduced the severity of COVID-19 cases. SARS-CoV-2 ongoing genome variations imply the use of confirmatory serologic biomarkers besides PCR for reliable diagnosis. MicroRNA molecules are intrinsic components of the innate immune system. The expression of miR155-5p and miR200c-3p was previously correlated with SARS-CoV-2 pathogenesis. This case-control study was conducted during the third peak of the COVID-19 pandemic in Egypt and aimed to calculate the accuracy of miR155-5p and miR200c-3p as biomarkers for COVID-19.
Methods and results: Thirty out of 400 COVID-19 patients at a main University hospital in Alexandria were included in the study along with 20 age-matched healthy controls. Plasma samples were collected for total and differential CBC. Relative quantitation of miR155-5p and miR200c-3p expression from WBCs was done by RT-qPCR. The expression of miR155-5p and miR200c-3p was positively correlated and was significantly downregulated in COVID-19 patients compared to the healthy control group (p ˂ 0.005). Both miR155-5p and miR200c-3p were of 76% and 74% accuracy as diagnostic biomarkers of COVID-19, respectively. Regarding the differentiation between mild and moderate cases, their accuracy was 80% and 70%, respectively.
Conclusions: miR155-5p and miR200c-3p expression can be used to confirm the diagnosis of COVID-19 and discriminate between mild and moderate cases, with a moderate degree of accuracy.
Keywords: COVID-19; Immune response; SARS-CoV-2 post mass-vaccination; miR155-5p; miR200c-3p; miRNA biomarkers.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Addressing the unsolved challenges in microRNA-based biomarker development: Suitable endogenous reference microRNAs for SARS-CoV-2 infection severity.Int J Biol Macromol. 2024 Jun;269(Pt 2):131926. doi: 10.1016/j.ijbiomac.2024.131926. Epub 2024 Apr 28. Int J Biol Macromol. 2024. PMID: 38688344
-
Differential microRNA expression in the peripheral blood from human patients with COVID-19.J Clin Lab Anal. 2020 Oct;34(10):e23590. doi: 10.1002/jcla.23590. Epub 2020 Sep 22. J Clin Lab Anal. 2020. PMID: 32960473 Free PMC article.
-
Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC.Int Immunopharmacol. 2021 Aug;97:107641. doi: 10.1016/j.intimp.2021.107641. Epub 2021 Apr 6. Int Immunopharmacol. 2021. PMID: 33895478 Free PMC article.
-
MicroRNAs as Potential Tools for Predicting Cancer Patients' Susceptibility to SARS-CoV-2 Infection and Vaccination Response.Cells. 2022 Jul 23;11(15):2279. doi: 10.3390/cells11152279. Cells. 2022. PMID: 35892576 Free PMC article. Review.
-
Circulatory microRNAs as potential biomarkers for different aspects of COVID-19.Arch Virol. 2024 Dec 12;170(1):8. doi: 10.1007/s00705-024-06184-3. Arch Virol. 2024. PMID: 39666114 Review.
References
-
- Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R (2020) COVID-19 infection: emergence, transmission, and characteristics of human coronaviruses. J Adv Res 24:91–98. https://doi.org/10.1016/j.jare.2020.03.005 - DOI - PMC - PubMed
-
- Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324(8):782–793. https://doi.org/10.1001/jama.2020.12839 - DOI - PubMed
-
- Smolen KK, Cai B, Gelinas L, Fortuno ES, Larsen M, Speert DP, Chamekh M, Cooper PJ, Esser M, Marchant A, Kollmann TR (2014) Single-cell analysis of innate cytokine responses to pattern recognition receptor stimulation in children across four continents. J Immunol 193(6):3003–3012. https://doi.org/10.4049/jimmunol.1400895 - DOI - PubMed
-
- Yazdanbakhsh M, Kremsner PG, Van Ree R (2002) Allergy, parasites, and the hygiene hypothesis. Science 296(5567):490–494. https://doi.org/10.1126/science.296.5567.490 - DOI - PubMed
-
- Saied AA, Metwally AA, Madkhali NAB, Haque S, Dhama K (2021) Egypt’s COVID-19 recent happenings and perspectives: a mini-review. Front Public Health 9. https://doi.org/10.3389/fpubh.2021.696082
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous